Cleared Special

K150375 - LIAISON VZV IgG, LIAISON Control VZV IgG (FDA 510(k) Clearance)

Mar 2015
Decision
26d
Days
Class 2
Risk

K150375 is an FDA 510(k) clearance for the LIAISON VZV IgG, LIAISON Control VZV IgG. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Varicella-zoster (Class II - Special Controls, product code LFY).

Submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on March 11, 2015, 26 days after receiving the submission on February 13, 2015.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3900.

Submission Details

510(k) Number K150375 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 2015
Decision Date March 11, 2015
Days to Decision 26 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LFY — Enzyme Linked Immunoabsorbent Assay, Varicella-zoster
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3900